Clinical Trial Update: Medium-term Effects of Molecular Hydrogen on Metabolic Fitness in Obesity [Phase 3]

View source ↗

Summary

Phase 3 trial investigating medium-term effects of molecular hydrogen on metabolic fitness in obesity has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Molecular Hydrogen (molecular hydrogen (H2))

Snippet

Sponsor: Center for Health Sciences, Serbia | Conditions: Obesity | Phase 3 | Status: COMPLETED